Arbutus Biopharma Corp Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 179.1M | 1.1M | 529K | 10.7M | 1.8M | 1.6M | 1.3M | 1.7M |
| Cost of Goods Sold | 11K | 11K | 11K | 0 | 9.0M | 8.8M | 0 | 0 |
| Gross Profit | 179.1M | 1.0M | 518K | 10.7M | -7.2M | -7.2M | 1.3M | 1.7M |
| R&D Expenses | 4.1M | 5.0M | 5.8M | 5.5M | 9.0M | 8.8M | 14.3M | 15.6M |
| Operating Expenses | 10.0M | 8.7M | 8.8M | 9.3M | 27.5M | 6.7M | 22.8M | 23.3M |
| Operating Income | 169.1M | -7.6M | -8.3M | 1.5M | -34.7M | -13.9M | -21.4M | -21.6M |
| Other Income / Gains | 578K | 3.9M | 551K | 1.0M | 10.1M | 1.4M | 1.7M | 1.8M |
| Net Income | 169.7M | -3.8M | -7.7M | 2.5M | -24.5M | -12.5M | -19.7M | -19.8M |
| EPS (Diluted) | 0.88 | -0.02 | -0.04 | 0.013 | -0.13 | -0.068 | -0.10 | -0.11 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 1.00 | 0.99 | 0.979 | 1.00 | -4.079 | -4.597 | 1.00 | 1.00 |
| General And Administrative Expenses | 5.9M | 3.7M | 3.0M | 3.3M | 5.8M | 8.4M | 4.5M | 7.5M |
| Selling And Marketing Expenses | 0 | 11K | -11K | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 5.9M | 3.7M | 3.0M | 3.3M | 5.8M | 8.4M | 4.5M | 7.5M |
| Other Expenses | 0 | -22K | 0 | 425K | 12.7M | -10.5M | 4.0M | 211K |
| Cost And Expenses | 10.0M | 8.7M | 8.8M | 9.3M | 36.4M | 15.5M | 22.8M | 23.3M |
| Interest Income | 815K | 877K | 952K | 1.0M | 1.2M | 1.5M | 1.7M | 1.8M |
| Interest Expense | 17K | 18K | 23K | 28K | 28K | 30K | 29K | 34K |
| Depreciation And Amortization | 11K | 11K | 11K | 11K | 333K | 333K | 336K | 356K |
| Ebitda | 169.7M | -3.7M | -7.7M | 2.6M | -24.2M | -15.3M | -19.4M | -19.4M |
| Ebitdaratio | 0.948 | -3.546 | -14.571 | 0.239 | -13.699 | -9.743 | -14.453 | -11.243 |
| Operating Income Ratio | 0.944 | -7.273 | -15.677 | 0.139 | -19.647 | -8.852 | -16.012 | -12.505 |
| Income Before Tax | 169.7M | -3.8M | -7.7M | 2.5M | -24.5M | -12.5M | -19.7M | -19.8M |
| Income Before Tax Ratio | 0.947 | -3.574 | -14.635 | 0.235 | -13.904 | -7.962 | -14.725 | -11.469 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0.947 | -3.574 | -14.635 | 0.235 | -13.904 | -7.962 | -14.725 | -11.469 |
| Epsdiluted | 0.87 | -0.02 | -0.04 | 0.013 | -0.13 | -0.068 | -0.10 | -0.11 |
| Weighted Average Shs Out | 193.8M | 191.6M | 191.8M | 191.6M | 190.7M | 185.6M | 189.0M | 188.0M |
| Weighted Average Shs Out Dil | 195.2M | 191.6M | 191.8M | 192.4M | 190.7M | 190.0M | 189.0M | 188.0M |